Key result
Protocol outlines review comparing renin inhibitors to ACE inhibitors for primary hypertension.
Why the study?
This Cochrane Review protocol aims to evaluate the efficacy and safety of renin inhibitors compared to ACE inhibitors in people with primary hypertension.
Population
People with primary hypertension
Comparison
Renin inhibitors vs ACE inhibitors
Design
Protocol for a Cochrane Review (Intervention)
Answers are grounded in this paper and cite their sources.
Protocol does not guide hypertension therapy; leaves open renin inhibitor versus ACE inhibitor efficacy and safety comparison.
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To evaluate the efficacy and safety of renin inhibitors compared to ACE inhibitors in people with primary hypertension.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2017) studied this question. Renin inhibitors will be compared to angiotensin converting enzyme (ACE) inhibitors to evaluate efficacy and safety in people with primary hypertension in this review protocol.
Synapse has enriched 10 related papers. Consider them for comparative context: